Bendamustine and cloretazine: Alkylators with sharply contrasting activity in AML

Francis J. Giles

doi:10.1080/10428190701332464

Bendamustine and cloretazine: Alkylators with sharply contrasting activity in AML

Francis J. Giles^*

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Comment/debate › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	1064-1066
Number of pages	3
Journal	Leukemia and Lymphoma
Volume	48
Issue number	6
DOIs	https://doi.org/10.1080/10428190701332464
State	Published - Jun 2007

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/10428190701332464

Cite this

@article{9be235dbb6784314bf1b9fd772a48319,

title = "Bendamustine and cloretazine: Alkylators with sharply contrasting activity in AML",

author = "Giles, {Francis J.}",

year = "2007",

month = jun,

doi = "10.1080/10428190701332464",

language = "English (US)",

volume = "48",

pages = "1064--1066",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "6",

}

TY - JOUR

T1 - Bendamustine and cloretazine

T2 - Alkylators with sharply contrasting activity in AML

AU - Giles, Francis J.

PY - 2007/6

Y1 - 2007/6

UR - http://www.scopus.com/inward/record.url?scp=34347349019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34347349019&partnerID=8YFLogxK

U2 - 10.1080/10428190701332464

DO - 10.1080/10428190701332464

M3 - Comment/debate

C2 - 17577766

AN - SCOPUS:34347349019

SN - 1042-8194

VL - 48

SP - 1064

EP - 1066

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 6

ER -

Bendamustine and cloretazine: Alkylators with sharply contrasting activity in AML

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this